or acquire any professional services or to enter into any obligation or transaction relating thereto; (f) Includes any extravagant claim, aggrandizement of abilities or self-laudatory statement calculated to attract patients, and which has a tendency to mislead the public or produce unrealistic expectations in particular cases; or (g) Is false, deceptive or misleading in regard to the price, cost, charge, fee or terms of credit or services performed or to be performed. 2. It is sufficient for disciplinary purposes that any statement or other advertising described in paragraph (e), (f) or (g) has a tendency to: (a) Deceive, mislead or harm the public because of its false, deceptive, misleading or harmful character; or (b) Produce unrealistic expectations in particular cases, even though no member of the public is actually deceived, misled or harmed, or no unrealistic expectations are actually produced by the statement or other advertising. [Bd. of Medical Exam’rs, § 630.190, eff. 12?20?79]—(NAC A 6?23?86) NAC 630.205 Appetite suppressants: Limitations on authority to prescribe. (NRS 630.130) 1. A physician or physician assistant who is authorized to prescribe controlled substances may prescribe an appetite suppressant to control the weight of a patient if the appetite suppressant is prescribed for use in the treatment of exogenous obesity as part of a program of medical treatment which includes dietary restrictions, modification of behavior and exercise and: (a) The physician or physician assistant determines that the patient’s obesity represents a threat to the patient’s health; or (b) The patient’s weight exceeds by not less than 20 percent the upper limit of the patient’s healthy weight as set forth in Figure 3 of Nutrition and Your Health: Dietary Guidelines for Americans, fourth edition, published jointly by the Department of Health and Human Services and the Department of Agriculture which the Board hereby adopts by reference. A copy of the publication may be obtained from the Consumer Information Center, Department 378-C, Pueblo, Colorado 81009, for the cost of $0.50. 2. A physician or physician assistant shall not prescribe an appetite suppressant for more than 3 months, unless the patient: (a) Has lost an average of not less than 2 pounds per month since he began taking the appetite suppressant; or (b) Has maintained his weight at the level which was established by his physician or a physician assistant under the supervision of his physician. 3. A physician or physician assistant who prescribes an appetite suppressant for more than 3 months shall maintain a record of the patient’s weight at the beginning and end of each month during which the patient takes the appetite suppressant. 4. Before prescribing an appetite suppressant, a physician or physician assistant shall obtain a medical history and perform a physical examination of the patient and conduct appropriate studies to determine if there are any contraindications to the use of the appetite suppressant by the patient. 5. As used in this section, “appetite suppressant” means a drug or other substance listed in schedule IV pursuant to NAC 453.540 which is used to suppress the appetite of a natural person. (Added to NAC by Bd. of Medical Exam’rs, eff. 7?18?96; A by R108?01, 11?29?2001) NAC 630.210 Consultation with another provider of health care. (NRS 630.130) A physician shall seek consultation with another provider of health care in doubtful or difficult cases whenever it appears that consultation may enhance the quality of medical services. [Bd. of Medical Exam’rs, § 630.210, eff. 12?20?79]—(NAC A 6?23?86) NAC 630.225 Reporting of unlicensed physician brought into this State for consultation with or assistance to licensed physician. (NRS 630.130) Any physician licensed in this State shall notify the Board if any unlicensed physician comes into this State for consultation with or assistance to the physician licensed in this State and specify the date of the consultation or assistance, whether the unlicensed physician has provided such consultation or assistance, or both, to the licensed physician in the past, and the date of that consultation and assistance. (Added to NAC by Bd. of Medical Exam’rs, eff. 6?23?86) NAC 630.230 Prohibited professional conduct. (NRS 630.130, 630.275) 1. A person who is licensed as a physician or physician assistant shall not: (a) Falsify records of health care; (b) Falsify the medical records of a hospital so as to indicate his presence at a time when he was not in attendance or falsify those records to indicate that procedures were performed by him which were in fact not performed by him; (c) Render professional services to a patient while the physician or physician assistant is under the influence of alcohol or any controlled substance or is in any impaired mental or physical condition; (d) Acquire any controlled substances from any pharmacy or other source by misrepresentation, fraud, deception or subterfuge; (e) Prescribe anabolic steroids for any person to increase muscle mass for competitive or athletic purposes; (f) Make an unreasonable additional charge for tests in a laboratory, radiological services or other services for testing which are ordered by the physician or physician assistant and performed outside his own office; (g) Prescribe controlled substances listed in schedule II pursuant to NAC 453.520 or schedule III pursuant to NAC 453.530, controlled substance analogs, chorionic gonadotrophic hormones, thyroid preparations or thyroid synthetics for the control of weight; (h) Allow any person to act as a medical assistant in the treatment of a patient of the physician or physician assistant, unless the medical assistant has sufficient training to provide the assistance; (i) Fail to provide adequate supervision of a medical assistant who is employed or supervised by the physician or physician assistant; (j) If the person is a physician, fail to provide adequate supervision of a physician assistant or an advanced practitioner of nursing; (k) Fail to honor the advance directive of a patient without informing the patient or the surrogate or guardian of the patient, and without documenting in the patient’s records the reasons for failing to honor the advance directive of the patient contained therein; or (l) Engage in the practice of writing prescriptions for controlled substances to treat acute pain or chronic pain in a manner that deviates from the guidelines set forth in the Model Guidelines for the Use of Controlled Substances for the Treatment of Pain adopted by reference in NAC 630.187. 2. As used in this section: (a) “Acute pain” has the meaning ascribed to it in section 3 of the Model Guidelines for the Use of Controlled Substances for the Treatment of Pain adopted by reference in NAC 630.187. (b) “Chronic pain” has the meaning ascribed to it in section 3 of the Model Guidelines for the Use of Controlled Substances for the Treatment of Pain adopted by reference in NAC 630.187. (c) “Controlled substance analog” means: (1) A substance whose chemical structure is substantially similar to the chemical structure of a controlled substance listed in schedule II pursuant to NAC 453.520 or schedule III pursuant to NAC 453.530; or (2) A substance which has, is represented as having or is intended to have a stimulant, depressant or hallucinogenic effect on the central nervous system of a person that is substantially similar to, or greater than, the stimulant, depressant or hallucinogenic effect on the central nervous system of a person of a controlled substance listed in schedule II pursuant to NAC 453.520 or schedule III pursuant to NAC 453.530. (d) “Medical assistant” means any person who: (1) Is employed by a physician or physician assistant; (2) Is unde

Vegas Law